SBFM
Sunshine Biopharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SBFM Filings
Filing Date
Form Description
Form Type
2025-11-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-23
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-10-23 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-10-23
Form DEF 14A - Other definitive proxy statements
Key Events
2025-10-23 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-09-30
Form 8-K - Current report
Key Events
2025-09-30 · Key Events
Form 8-K - Current report
2025-08-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-13
Form EFFECT - Notice of Effectiveness
2025-08-13 ·
Form EFFECT - Notice of Effectiveness
2025-08-12
Form RW - Registration Withdrawal Request
2025-08-12 ·
Form RW - Registration Withdrawal Request
2025-08-12
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-08-12 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-08-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-08-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-08-11
Form CORRESP - Correspondence
SEC Inquiries
2025-08-11 · SEC Inquiries
Form CORRESP - Correspondence
